Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nanaumi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Japanese Journal of Cancer Research : Gann|April 1, 1992
Cell-killing activity and kinetic analysis of a novel antitumor compound NC-190, a benzo[a]phenazine derivativeS Nakaike, T Yamagishi, K Nanaumi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The effect of NC-190, a novel antitumor compound, on the cell-cycle progression of HeLa S3 cellsT Yamagishi, S Nakaike, K Nanaumi, et al.
European Journal of Pharmacology|May 30, 1997
Overcoming of multidrug resistance by VA-033, a novel derivative of apovincaminic acid esterK Nanaumi, K Tsuchida, S Nakaike, et al.
International Journal of Cancer|November 10, 2000
Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G(1) phase of the cell cycleK Fukuoka, T Yamagishi, T Ichihara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Japanese Journal of Cancer Research : Gann|April 1, 1992
Cell-killing activity and kinetic analysis of a novel antitumor compound NC-190, a benzo[a]phenazine derivativeS Nakaike, T Yamagishi, K Nanaumi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The effect of NC-190, a novel antitumor compound, on the cell-cycle progression of HeLa S3 cellsT Yamagishi, S Nakaike, K Nanaumi, et al.
European Journal of Pharmacology|May 30, 1997
Overcoming of multidrug resistance by VA-033, a novel derivative of apovincaminic acid esterK Nanaumi, K Tsuchida, S Nakaike, et al.
International Journal of Cancer|November 10, 2000
Mechanism of action of aragusterol a (YTA0040), a potent anti-tumor marine steroid targeting the G(1) phase of the cell cycleK Fukuoka, T Yamagishi, T Ichihara, et al.
Pageof 1